IDDO is working with the global schistosomiasis and STHs research community and stakeholders to develop and sustain a data platform, which collates individual patient data (IPD) before and after treatment with antiparasitic drugs from clinical studies to deliver robust science and address knowledge gaps.
This Research Agenda was originally drafted by the IDDO team and the Scientific Advisory Committee, SAC, before being reviewed, first by a larger audience of identified experts from across the schistosomiasis and STHs communities, and then openly. The questions are those that can be addressed by using individual patient data from clinical trials around the world that have been pooled and standardised on the schistosomiasis and STHs data platform.
The research agenda is a live document and feedback is always welcome.
Download the agenda here.
You can provide feedback on the Research Agenda by contacting IDDO via email at firstname.lastname@example.org